Mgr. Bohumil Fafílek, Ph.D.
Researcher, Section of Animal Physiology and Immunology
office: bldg. D36/118
Kamenice 753/5
625 00 Brno
phone: | +420 549 49 8609 |
---|---|
e‑mail: |
social and academic networks: |
---|
Total number of publications: 21
2024
-
Discovery of Two Highly Selective Structurally Orthogonal Chemical Probes for Activin Receptor-like Kinases 1 and 2
Journal of Medicinal Chemistry, year: 2024, volume: 67, edition: 15, DOI
-
Ligand bias underlies differential signaling of multiple FGFs via FGFR1
elife, year: 2024, volume: 12, edition: April 2024, DOI
2022
-
4-PBA Treatment Improves Bone Phenotypes in the Aga2 Mouse Model of Osteogenesis Imperfecta
Journal of bone and mineral research, year: 2022, volume: 37, edition: 4, DOI
-
Expanding horizons of achondroplasia treatment: current options and future developments
Osteoarthritis and Cartilage, year: 2022, volume: 30, edition: 4, DOI
-
LuminoCell: a versatile and affordable platform for real-time monitoring of luciferase-based reporters
Life science alliance, year: 2022, volume: 5, edition: 8, DOI
2021
-
An RNA aptamer restores defective bone growth in FGFR3-related skeletal dysplasia in mice
Science Translational Medicine, year: 2021, volume: 13, edition: 592, DOI
2020
-
Elucidation of protein interactions necessary for the maintenance of the BCR-ABL signaling complex
Cellular and molecular life sciences, year: 2020, volume: 77, edition: 19, DOI
2019
-
Fibroblast growth factor receptor influences primary cilium length through an interaction with intestinal cell kinase
Proceedings of the National Academy of Sciences of the United States of America, year: 2019, volume: 116, edition: 10, DOI
2018
-
The inositol phosphatase SHIP2 enables sustained ERK activation downstream of FGF receptors by recruiting Src kinases
SCIENCE SIGNALING, year: 2018, volume: 11, edition: 548, DOI
2017
-
Inhibitor repurposing reveals ALK, LTK, FGFR, RET and TRK kinases as the targets of AZD1480
Oncotarget, year: 2017, volume: 8, edition: 65, DOI